[1]
R., S. and S., U. 2017. Usage of lipid-lowering drugs such as atorvastatin and rosuvastatin in the management of hyperlipidemia in multiple vessel wall block patients. International Journal of Basic & Clinical Pharmacology. 7, 1 (Dec. 2017), 133–137. DOI:https://doi.org/10.18203/2319-2003.ijbcp20175688.